Pooled Efficacy and Safety Results from the DERMIS-1 and DERMIS-2 Phase 3 Trials of Once-Daily Roflumilast Cream 0.3% for Treatment of Chronic Plaque Psoriasis
Authors: Mark Lebwohl, Melinda J. Gooderham, Scott Guenthner, H. Chih-ho Hong, Leon Kircik, Angela Moore, Matthew Zirwas, Amy Feng, Robert C. Higham, Patrick Burnett, David R. Berk
< PREVIOUS POSTER NEXT POSTER >
